{"conversation_id": "1261285533302640640", "entities": {"mentions": [{"start": 193, "end": 207, "username": "laurapdavison", "id": "17417739"}], "annotations": [{"start": 81, "end": 84, "probability": 0.969, "type": "Place", "normalized_text": "U.S."}, {"start": 135, "end": 149, "probability": 0.4113, "type": "Organization", "normalized_text": "Federal Reserve"}], "urls": [{"start": 169, "end": 192, "url": "https://t.co/YOUZiDyUEh", "expanded_url": "https://www.bloomberg.com/news/articles/2020-05-15/firms-that-left-u-s-for-tax-reasons-could-qualify-for-fed-s-aid", "display_url": "bloomberg.com/news/articles/\u2026"}]}, "id": "1261285533302640640", "created_at": "2020-05-15T13:21:19.000Z", "possibly_sensitive": false, "author_id": "36510873", "reply_settings": "everyone", "text": "NEW: American companies that moved their official headquarters offshore to avoid U.S. taxes could qualify for coronavirus aid from the\u00a0Federal Reserve, tax lawyers say\n\nhttps://t.co/YOUZiDyUEh @laurapdavison", "public_metrics": {"retweet_count": 286, "reply_count": 40, "like_count": 244, "quote_count": 109}, "lang": "en", "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}, {"domain": {"id": "29", "name": "Events [Entity Service]", "description": "Entity Service related Events domain"}, "entity": {"id": "1219057585707315201", "name": "COVID-19: Latest news updates from around the world", "description": "This page is a timeline of Tweets with the latest information and updates on COVID-19 from experts, journalists, health authorities and other trusted sources from around the world. For more on COVID-19, visit: twitter.com/explore/tabs/covid-19"}}, {"domain": {"id": "29", "name": "Events [Entity Service]", "description": "Entity Service related Events domain"}, "entity": {"id": "1257611892941402116", "name": "Coronavirus: Human trials for experimental vaccine begin in the US", "description": "Pharmaceutical companies Pfizer and BioNTech confirmed the start of human trials for a potential coronavirus vaccine. If successful, the vaccine could be in \"emergency use\" starting in September, officials say.\n\n\ud83c\udf0dUpdates: 15 NY children diagnosed with syndrome possibly tied to COVID-19\n\ud83c\uddfa\ud83c\uddf3 Public Health: Info from health agencies \n\ud83d\udcc8 By the numbers: Data to understand the impact \n\ud83d\udcab Positivity: Turkish sheep take to the streets\n\u2705 Fact-check: Misinformation debunked \n\ud83d\udcdd Lists: Accounts to follow"}}], "source": "TweetDeck"}